Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The molecular controls of resolution of inflammation: what can we learn from zebrafish?

StephenA. Renshaw, CatherineA. Loynes, DanielM. Trushell, PhilipW. Ingham, MoiraK. B. Whyte
European Respiratory Review 2006 15: 168-169; DOI: 10.1183/09059180.00010108
StephenA. Renshaw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CatherineA. Loynes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DanielM. Trushell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PhilipW. Ingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MoiraK. B. Whyte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Although we are separated from zebrafish by 160 million years of evolution, we share many features of the innate and adaptive immune systems. In addition, we can manipulate the genome of zebrafish, and observe the effects on inflammation in vivo as they are transparent in their larval stages. This has exciting implications for the study of inflammatory diseases.

We have established a model of inflammation in the zebrafish tail, in which caspase dependent cell death is required for resolution. For example, addition of the pan-caspase inhibitor zVD added at 4 hours after tailfin injury increases the number of neutrophils present from 6.0+/−1.0 to 28.9+/− 3.3 (mean +/− s.e.m. p<0.001 n = 3).

The transparency of the larvae makes these an ideal model for the study of in vivo inflammation, and we have generated fluorescent systems for the easy visualisation of neutrophilic inflammation and resolution in vivo.

We are also performing an unbiased forward genetic screen for mutants with defective resolution of inflammation, and to date have identified 38 putative mutants. These techniques allow new approaches to understanding the molecular controls of inflammation resolution.

MY JOB AND THE UNIT IN WHICH I WORK

I am an MRC Clinician Scientist, Senior Clinical Lecturer and Honorary Consultant Respiratory Physician working at the University of Sheffield School of Medicine and Biomedical Sciences (Sheffield, UK). I am currently establishing a research group to extend my studies of the role of neutrophils in inflammatory lung disease into a novel model of inflammation in the zebrafish, Danio rerio. To that end, I have initiated a very successful collaboration with Prof. Philip Ingham, FRS, in the MRC Centre for Developmental and Biomedical Genetics within the University. I have laboratory space within the Centre, where we need access to both the aquaria and the expertise available. When I am not working in the laboratory, I spend my time at the Royal Hallamshire Hospital, where I perform clinical sessions and other duties within the Medical School. I participate in the rota to provide cover to the in-patient respiratory service and perform general medical tasks during this time. I also cover clinics and bronchoscopy sessions from time to time. I am subspeciality lead for pleural disease in Sheffield and am currently working to establish a local anaesthetic thoracoscopy service within the Sheffield hospitals.

MY WINNING POSTER AS PART OF MY RESEARCH

My research interest in the molecular mechanisms underlying inflammatory lung disease has come from my clinical interest in this broad group of diseases. Since beginning my PhD studies with Prof. Moira Whyte in 1998, I have been interested in the molecular controls of neutrophil lifespan and how this relates to the resolution of inflammation. We believe that the process is controlled by a series of molecular events, leading to the death of neutrophils by apoptosis. Thus, regulators of apoptosis regulate inflammation. My PhD thesis explored the role of a family of death receptors on the neutrophil surface [1, 2] and their intracellular signalling pathways [3], which may be involved in regulating inflammation in vivo, but also give the potential to target neutrophil lifespan therapeutically. However, work on human neutrophils is limited by their genetic intractability and I had been seeking alternative model systems for some time. We are very fortunate in Sheffield to have a world-leading zebrafish group led by Prof. Philip Ingham. In collaboration with Prof. Ingham, I have established a model of resolving inflammation, in which individual neutrophils can be visualised easily in vivo in real time [4]. We have established that inhibition of apoptosis proteases (caspases) causes delay of resolution of inflammation in this model. The real strengths of zebrafish models are the ability to perform forward (unbiased) and reverse (candidate gene) genetic screens for the molecules involved in inflammation. These screens are underway and I hope to be reporting their results within the next 1–2 yrs.

MY RESEARCH AS PART OF MY WORKING GROUP/RESEARCH TEAM

The Academic Unit of Respiratory Medicine (AURM) is headed by Prof. Moira Whyte. Other principal investigators in the AURM are Prof. Ian Sabroe, Dr David Dockrell, Dr Colin Bingle, Dr Sarah Walmsley and myself. My own interests in the molecular controls of the resolution of inflammation are mirrored by many within the group. The uniting theme of the research group is the interaction of the host innate immune system with pathogens. Ian Sabroe is a Medical Research Council Senior Clinical Fellow and has diverse interests, but his main research topic is the influence of signalling through Toll-like receptors on neutrophil biology. David Dockrell is a Wellcome Trust Senior Clinical Fellow and is interested in the effect on the biology of the macrophage of interactions with pathogens, particularly Streptococcus pneumoniae. Colin Bingle is Senior Lecturer and, among his widespread interests, the novel peptides involved in the innate immune response to pathogens are an emerging focus for his work. Sarah Walmsley is a Wellcome Trust Intermediate Fellow, with an interest in the role of hypoxic signalling in regulating inflammatory neutrophil biology. Many of these programmes of work study mechanisms of neutrophil apoptosis, and there is much collaboration and cross-fertilisation of ideas. We use a number of models to study these processes, including cell lines, primary human neutrophils (either in culture alone or with other relevant cells), and in vivo models including the zebrafish.

There are other respiratory research programmes within respiratory medicine in Sheffield, notably those of David Fishwick and Christopher Barber, who study occupational lung diseases and work closely with the Health and Safety Laboratories in Buxton.

THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE

Inflammatory disease is in need of new treatments. The treatments we have are poorly effective for many of the conditions they are used for and are beset by side-effects. Understanding how inflammation resolves would allow us to understand how it might fail to do so in inflammatory disease, and thus identify targets for the development of novel classes of drug. My model will allow real-time visualisation of inflammation as it occurs and also permit genetic manipulations, including forward genetic screens. This will allow us to come to a better understanding of the genetic controls of the resolution of inflammation. It is my hope that this will allow identification of critical control points, where small molecules may be able to target inhibition of normal resolution allowing it to proceed unhindered. In fact, zebrafish models such as this are ideal for screening for novel drugs targeting the immune response. I would hope that this model will inform many aspects of inflammatory cell biology and lead to a better understanding of this essential physiological process.

  FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Following injury to the tail fin of a transgenic zebrafish larva at 3 days post-fertilisation, green fluorescent protein-positive fluorescent neutrophils can be seen accumulating at the site of injury. The images shown are taken 15 min apart and read from left to right and top to bottom.

    • © ERSJ Ltd

    References

    1. ↵
      Renshaw SA, Timmons SJ, Eaton V, et al. Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. J Leukoc Biol 2000; 67: 662–668.
      OpenUrlAbstract
    2. ↵
      Renshaw SA, Parmar JS, Singleton V, et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 2003; 170: 1027–1033.
      OpenUrlAbstract/FREE Full Text
    3. ↵
      Renshaw SA, Dempsey CE, Barnes FA, et al. Three novel Bid proteins generated by alternative splicing of the human Bid gene. J Biol Chem 2004; 279: 2846–2855.
      OpenUrlAbstract/FREE Full Text
    4. ↵
      Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. Blood 2006; 108: 3976–3978.
      OpenUrlAbstract/FREE Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 15 Issue 101 Table of Contents
    European Respiratory Review: 15 (101)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The molecular controls of resolution of inflammation: what can we learn from zebrafish?
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    The molecular controls of resolution of inflammation: what can we learn from zebrafish?
    StephenA. Renshaw, CatherineA. Loynes, DanielM. Trushell, PhilipW. Ingham, MoiraK. B. Whyte
    European Respiratory Review Dec 2006, 15 (101) 168-169; DOI: 10.1183/09059180.00010108

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    The molecular controls of resolution of inflammation: what can we learn from zebrafish?
    StephenA. Renshaw, CatherineA. Loynes, DanielM. Trushell, PhilipW. Ingham, MoiraK. B. Whyte
    European Respiratory Review Dec 2006, 15 (101) 168-169; DOI: 10.1183/09059180.00010108
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • MY JOB AND THE UNIT IN WHICH I WORK
      • MY WINNING POSTER AS PART OF MY RESEARCH
      • MY RESEARCH AS PART OF MY WORKING GROUP/RESEARCH TEAM
      • THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • The psychobiology of nicotine dependence
    • Smoking and impact on health
    • Nonpharmacological smoking cessation interventions in clinical practice
    Show more Original Articles

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2023 by the European Respiratory Society